Bio-Path Holdings, Inc. Gains 27.98%
Thu, Oct 22, 2020 at 05:30 PM
Bio-Path Holdings, Inc. (BPTH:NASDAQ) shot up at $5.26, a gain of 28%. On Wed 21 Oct 20, BPTH:NASDAQ touched a New 2-Week Intraday Low of $3.94. The stock appeared on our News Catalysts scanner on Thu 22 Oct 20 at 10:52 AM in the 'MERGER' category. From Wed 07 Oct 20, the stock recorded 30.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Bio-Path Holdings, Inc. (BPTH:NASDAQ)
Bio-Path Holdings Inc is a clinical & preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.
Top 10 Gainers:
- Ever-Glory International Group, Inc. (EVK:NASDAQ), 122.22%
- TuanChe Limited (TC:NASDAQ), 98.36%
- KBS Fashion Group Limited (KBSF:NASDAQ), 63.6%
- Sequential Brands Group, Inc. (SQBG:NASDAQ), 47.89%
- Westell Technologies, Inc. (WSTL:NASDAQ), 45%
- Align Technology, Inc. (ALGN:NASDAQ), 34.97%
- OEG (OEG:NASDAQ), 34.45%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 27.98%
- Concord Medical Services Holdings Limited (CCM:NYSE), 23.13%
- Birks Group Inc. (BGI:NYSEMKT), 22.31%